D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study-Reference-Cited by-同舟云学术

D-dimer to guide the duration of anticoagulation in patients with venous thromboembolism: a management study

Published:2014-07-10 Issue:2 Volume:124 Page:196-203
ISSN:0006-4971
Container-title:Blood
language:en
Short-container-title:

Author:

Palareti Gualtiero¹,Cosmi Benilde¹,Legnani Cristina¹,Antonucci Emilia²,De Micheli Valeria³,Ghirarduzzi Angelo⁴,Poli Daniela²,Testa Sophie⁵,Tosetto Alberto⁶,Pengo Vittorio⁷,Prandoni Paolo⁸

Affiliation:

1. Angiology and Blood Coagulation, University Hospital of Bologna, Bologna, Italy;

2. Thrombosis Centre, Department Heart and Vessels, University Hospital of Florence, Florence, Italy;

3. Haemostasis and Thrombosis Centre, Hospital of Lecco, Lecco, Italy;

4. Internal Medicine, ASMN-IRCCS-Reggio Emilia, Reggio nell'Emilia, Italy;

5. Haemostasis and Thrombosis Centre, Hospital of Cremona, Cremona, Italy;

6. Haematology and Thrombosis Centre, Hospital of Vicenza, Vicenza, Italy; and

7. Department of Cardiothoracic and Vascular Sciences and

8. Internal Medicine, Department of Medical and Surgical Sciences, University Hospital of Padua, Padua, Italy

Abstract

Key Points The duration of anticoagulation after VTE is uncertain; this management study intended to identify patients with low/high recurrence risk. Patients with persistently negative D-dimers after stopping standard therapy have a low recurrence risk and can stop anticoagulation.

Publisher

American Society of Hematology

Subject

Cell Biology,Hematology,Immunology,Biochemistry

Link

http://ashpublications.org/blood/article-pdf/124/2/196/1381020/196.pdf

Reference30 articles.

1. Thrombophilia, clinical factors, and recurrent venous thrombotic events.;Christiansen;JAMA,2005

2. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients.;Prandoni;Haematologica,2007

3. Antithrombotic therapy for VTE disease: antithrombotic therapy and prevention of thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.;Kearon;Chest,2012

4. Three months versus one year of oral anticoagulant therapy for idiopathic deep venous thrombosis.;Agnelli;N Engl J Med,2001

5. Influence of preceding length of anticoagulant treatment and initial presentation of venous thromboembolism on risk of recurrence after stopping treatment: analysis of individual participants’ data from seven trials.;Boutitie;BMJ,2011

Cited by 157 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Anticoagulation and compression therapy for proximal acute deep vein thrombosis;Vasa;2024-07-17

2. D-dimer and risk of venous thromboembolism recurrence: Comparison of two studies with similar designs but different laboratory and clinical results;Thrombosis Research;2024-06

3. Overall haemostatic potential assay for prediction of outcomes in venous and arterial thrombosis and thrombo-inflammatory diseases;Journal of Thrombosis and Thrombolysis;2024-04-22

4. Management of Deep Vein Thrombosis: An Update Based on the Revised AWMF S2k Guideline;Hämostaseologie;2024-04

5. Building Synthetic Biosensors Using Red Blood Cell Proteins;ACS Synthetic Biology;2024-03-27